TEVA 7334 (Mycophenolate mofetil 250 mg)
This pill with imprint "TEVA 7334" is Blue & Orange, Capsule-shape and has been identified as Mycophenolate mofetil 250 mg. It is manufactured by Teva Pharmaceuticals USA.
Mycophenolate mofetil is used in the treatment of nephrotic syndrome; systemic lupus erythematosus; myasthenia gravis; rheumatoid arthritis; bullous pemphigoid (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- TEVA 7334
- Strength:
- 250 mg
- Color:
- Blue & Orange
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Selective immunosuppressants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-7334
More about mycophenolate mofetil
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 41 Reviews – Add your own review/rating
- Drug class: selective immunosuppressants
Consumer resources
- Mycophenolate mofetil
- Mycophenolate mofetil capsules
- Mycophenolate mofetil solution
- Mycophenolate mofetil suspension
- Mycophenolate Intravenous (Advanced Reading)
- Mycophenolate mofetil (Advanced Reading)
Other brands: CellCept
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
